Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Pulmonary Hypertension, March 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 136 articles:
HTML format


 

Single Articles

  1. SATO T, Ohira H, Tsujino I
    Representative Chest Auscultation Findings in Pulmonary Hypertension: Phonocardiograms and Sound Clips.
    Ann Am Thorac Soc. 2017 Mar 2. doi: 10.1513/AnnalsATS.201612-1031.
    Abstract    

    Abstract available


  2. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology.
    Eur J Heart Fail. 2017;19:439.
    Abstract    




  3. Tsujii N, Shiraishi I, Kokame K, et al. Severe Hemolysis and Pulmonary Hypertension in a Neonate With Upshaw-Schulman Syndrome. Pediatrics. 2016:138(6):e20161565.
    Pediatrics. 2017;139.
    Abstract    



  4. POUSADA G, Baloira A, Valverde D
    Mutational screening in genes related to porto-pulmonary hypertension: An analysis of 6 cases.
    Med Clin (Barc). 2017 Feb 25. pii: S0025-7753(17)30091.
    Abstract    

    Abstract available

  5. EMMENS JE, Ter Maaten JM, Voors AA
    Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure?
    Eur J Heart Fail. 2017 Feb 28. doi: 10.1002.
    Abstract    



  6. WONG HT, Chee KH, Chong AW
    Pulmonary hypertension and echocardiogram parameters in obstructive sleep apnea.
    Eur Arch Otorhinolaryngol. 2017 Feb 27. doi: 10.1007/s00405-017-4491.
    Abstract    

    Abstract available

  7. MAZUREK JA, Horne BD, Saeed W, Sardar MR, et al
    Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension.
    Heart Lung Circ. 2017 Feb 8. pii: S1443-9506(17)30032.
    Abstract    

    Abstract available

  8. HOEPER MM, Ghofrani HA, Grunig E, Klose H, et al
    Pulmonary Hypertension.
    Dtsch Arztebl Int. 2017;114:73-84.
    Abstract    

    Abstract available

  9. SERRANO-PARRENO B, Carreton E, Caro-Vadillo A, Falcon-Cordon Y, et al
    Evaluation of pulmonary hypertension and clinical status in dogs with heartworm by Right Pulmonary Artery Distensibility Index and other echocardiographic parameters.
    Parasit Vectors. 2017;10:106.
    Abstract    

    Abstract available

  10. SIEGEL Y, Bleicher D, Gordon MK, Fertel D, et al
    Computed Tomography Pulmonary Angiogram Dynamic Parameter Correlation With Pulmonary Pressure and Pulmonary Hypertension Etiologies.
    J Comput Assist Tomogr. 2017 Feb 24. doi: 10.1097/RCT.0000000000000582.
    Abstract    

    Abstract available

  11. HAREL F, Langleben D, Provencher S, Fournier A, et al
    Molecular imaging of the human pulmonary vascular endothelium in pulmonary hypertension: a phase II safety and proof of principle trial.
    Eur J Nucl Med Mol Imaging. 2017 Feb 24. doi: 10.1007/s00259-017-3655.
    Abstract    

    Abstract available

  12. UNEGBU C, Noje C, Coulson JD, Segal JB, et al
    Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors.
    Pediatrics. 2017;139.
    Abstract    

    Abstract available

  13. DEDEOGLU S, Bornaun H
    Pulmonary Hypertension in Children With beta Thalassemia Major, Are Splenectomy and High-Ferritin Levels Related or Not?
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000803.
    Abstract    

    Abstract available

  14. LOPEZ GUDE MJ, Perez de la Sota E, Perez Vela JL, Centeno Rodriguez J, et al
    Pulmonary endarterectomy outputs in chronic thromboembolic pulmonary hypertension.
    Med Clin (Barc). 2017 Feb 20. pii: S0025-7753(17)30035.
    Abstract    

    Abstract available

  15. SHI Z, Wu H, Luo J, Sun X, et al
    STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation.
    Biomed Pharmacother. 2017;87:397-404.
    Abstract    

    Abstract available

  16. ZHANG WF, Xiong YW, Zhu TT, Xiong AZ, et al
    MicroRNA let-7g inhibited hypoxia-induced proliferation of PASMCs via G0/G1 cell cycle arrest by targeting c-myc.
    Life Sci. 2017;170:9-15.
    Abstract    

    Abstract available

  17. HU Y, Qiu JX, Liao JP, Zhang H, et al
    Clinical Manifestations of Fibrosing Mediastinitis in Chinese Patients.
    Chin Med J (Engl). 2016;129:2697-2702.
    Abstract    

    Abstract available

  18. HERRERA S, Gabrielli L, Paredes A, Saavedra R, et al
    [Survival of patients with pulmonary arterial hypertension after the advent of specific pulmonary vasodilator therapies].
    Rev Med Chil. 2016;144:829-36.
    Abstract    

    Abstract available

  19. SATO H, Miura M, Yaoita N, Yamamoto S, et al
    Pulmonary Arterial Hypertension Associated with Congenital Portosystemic Shunts Treated with Transcatheter Embolization and Pulmonary Vasodilators.
    Intern Med. 2016;55:2429-32.
    Abstract    

    Abstract available

  20. RICHTER MJ, Gall H, Grimminger J, Grimminger F, et al
    Selexipag for the treatment of pulmonary arterial hypertension.
    Expert Opin Pharmacother. 2016;17:1825-34.
    Abstract    

    Abstract available

  21. ZHUO Y, Zeng Q, Zhang P, Li G, et al
    Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people.
    Clin Chem Lab Med. 2017;55:38-46.
    Abstract    

    Abstract available

  22. LU HI, Huang TH, Sung PH, Chen YL, et al
    Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice.
    Acta Pharmacol Sin. 2016;37:589-603.
    Abstract    

    Abstract available

  23. PAN D, Liu R, Ren S, Li C, et al
    Prediction of Pulmonary Arterial Hypertension in Chronic Obstructive Lung Disease from Three-Dimensional Vectorcardiographic Parameters.
    Ann Noninvasive Electrocardiol. 2016;21:280-6.
    Abstract    

    Abstract available

  24. MOURATOGLOU SA, Giannakoulas G, Deftereos S, Giannopoulos G, et al
    Intra--and Intercellular Calcium Handling in Pulmonary Arterial Hypertension.
    Med Chem. 2016;12:162-9.
    Abstract    

    Abstract available

  25. MATURA LA, McDonough A, Carroll DL
    Symptom Prevalence, Symptom Severity, and Health-Related Quality of Life Among Young, Middle, and Older Adults With Pulmonary Arterial Hypertension.
    Am J Hosp Palliat Care. 2016;33:214-21.
    Abstract    

    Abstract available

  26. PANAGIOTIDOU E, Sourla E, Kotoulas SX, Akritidou S, et al
    Rheumatoid arthritis associated pulmonary hypertension: Clinical challenges reflecting the diversity of pathophysiology.
    Respir Med Case Rep. 2017;20:164-167.
    Abstract    

    Abstract available


  27. [Experts consensus on the management of neonatal pulmonary hypertension].
    Zhonghua Er Ke Za Zhi. 2017;55:163-168.
    Abstract    




  28. [Lessons learned from the diagnosis and treatment of pulmonary hypertension in the neonates].
    Zhonghua Er Ke Za Zhi. 2017;55:161-162.
    Abstract    



  29. YAYLALI YT
    How to select the appropriate candidate of pulmonary arterial hypertension: specific therapy in elderly patients with pulmonary hypertension.
    J Geriatr Cardiol. 2017;14:17-19.
    Abstract    



  30. OREM C
    Epidemiology of pulmonary hypertension in the elderly.
    J Geriatr Cardiol. 2017;14:11-16.
    Abstract    



  31. MCDIVITT JD, Barstow C
    Cardiovascular Disease Update: Pulmonary Hypertension.
    FP Essent. 2017;454:24-28.
    Abstract    

    Abstract available

  32. TIAN L, Neuber-Hess M, Mewburn J, Dasgupta A, et al
    Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension.
    J Mol Med (Berl). 2017 Mar 6. doi: 10.1007/s00109-017-1522.
    Abstract    

    Abstract available

  33. WU F, Hao Y, Yang J, Yao W, et al
    Protective effects of aloperine on monocrotaline-induced pulmonary hypertension in rats.
    Biomed Pharmacother. 2017;89:632-641.
    Abstract    

    Abstract available

  34. GOLOB MJ, Tabima DM, Wolf GD, Johnston JL, et al
    Pulmonary arterial strain- and remodeling-induced stiffening are differentiated in a chronic model of pulmonary hypertension.
    J Biomech. 2017 Feb 21. pii: S0021-9290(17)30099.
    Abstract    

    Abstract available

  35. JIANG C, Qian H, Luo S, Lin J, et al
    Vasopressors induce passive pulmonary hypertension by blood redistribution from systemic to pulmonary circulation.
    Basic Res Cardiol. 2017;112:21.
    Abstract    

    Abstract available

  36. KIMURA M, Kohno T, Kawakami T, Kataoka M, et al
    Midterm Effect of Balloon Pulmonary Angioplasty on Hemodynamics and Subclinical Myocardial Damage in Chronic Thromboembolic Pulmonary Hypertension.
    Can J Cardiol. 2016 Dec 8. pii: S0828-282X(16)31145.
    Abstract    

    Abstract available

  37. BOUCHACOURT JP, Riva J, Grignola JC
    Pulmonary hypertension attenuates the dynamic preload indicators increase during experimental hypovolemia.
    BMC Anesthesiol. 2017;17:35.
    Abstract    

    Abstract available

  38. LIU N, Parry S, Xiao Y, Zhou S, et al
    Molecular targets of the Warburg effect and inflammatory cytokines in the pathogenesis of pulmonary artery hypertension.
    Clin Chim Acta. 2017;466:98-104.
    Abstract    

    Abstract available

  39. JAYAPRASAD N, Madhavan S
    Severe pulmonary arterial hypertension in a patient with small ventricular septal defect.
    BMJ Case Rep. 2017;2017.
    Abstract    



  40. WANG JJ, Zuo XR, Xu J, Zhou JY, et al
    Evaluation and Treatment of Endoplasmic Reticulum (ER) Stress in Right Ventricular Dysfunction during Monocrotaline-Induced Rat Pulmonary Arterial Hypertension.
    Cardiovasc Drugs Ther. 2016;30:587-598.
    Abstract    

    Abstract available

  41. DIAZ GC, O'Connor MF, Renz JF
    Anesthesia for Patients with Concomitant Hepatic and Pulmonary Dysfunction.
    Anesthesiol Clin. 2016;34:797-808.
    Abstract    

    Abstract available

  42. AHDOUT J, Nurok M
    Anesthesia Patients with Concomitant Cardiac and Hepatic Dysfunction.
    Anesthesiol Clin. 2016;34:731-745.
    Abstract    

    Abstract available

  43. MALACZYNSKA-RAJPOLD K, Araszkiewicz A, Mularek-Kubzdela T
    Balloon atrial septostomy in pulmonary arterial hypertension: A beneficial effect on the control of rhythm abnormalities.
    Cardiol J. 2016;23:539-540.
    Abstract    



  44. MALACZYNSKA-RAJPOLD K, Kurzyna M, Koteja A, Torbicki A, et al
    The "bouncing" catheter.
    Cardiol J. 2016;23:552-553.
    Abstract    



  45. DE AMORIM CORREA R, de Oliveira FB, Barbosa MM, Barbosa JA, et al
    Left Ventricular Function in Patients with Pulmonary Arterial Hypertension: The Role of Two-Dimensional Speckle Tracking Strain.
    Echocardiography. 2016;33:1326-34.
    Abstract    

    Abstract available

  46. IGARASHI A, Inoue S, Ishii T, Tsutani K, et al
    Comparative Effectiveness of Oral Medications for Pulmonary Arterial Hypertension.
    Int Heart J. 2016;57:466-72.
    Abstract    

    Abstract available

  47. MATURA LA, McDonough A, Hanlon AL, Carroll DL, et al
    Developmental and Initial Validation of the Pulmonary Arterial Hypertension Symptom Inference Scale.
    J Nurs Meas. 2016;24:40-53.
    Abstract    

    Abstract available

  48. VANDECASTEELE EH, De Pauw M, Brusselle G, Decuman S, et al
    The heart and pulmonary arterial hypertension in systemic sclerosis.
    Acta Clin Belg. 2016;71:1-18.
    Abstract    

    Abstract available

  49. LI L, Dong P, Hou C, Cao F, et al
    Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
    J Ethnopharmacol. 2016;186:224-33.
    Abstract    

    Abstract available

  50. BORRACCI RA, Rubio M, Sestito ML, Ingino CA, et al
    Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor(R) porcine prosthetic valves.
    Cardiol J. 2016;23:178-83.
    Abstract    

    Abstract available

  51. YAMASAKI Y, Nagao M, Kamitani T, Yamanouchi T, et al
    Clinical impact of left ventricular eccentricity index using cardiac MRI in assessment of right ventricular hemodynamics and myocardial fibrosis in congenital heart disease.
    Eur Radiol. 2016;26:3617-25.
    Abstract    

    Abstract available

  52. CHERNYAVSKY AM, Edemsky AG, Chernyavsky MA, Tarkova AR, et al
    [5-year surgical results in patients with chronic postembolic pulmonary hypertension].
    Khirurgiia (Mosk). 2017;:21-24.
    Abstract    

    Abstract available

  53. HOLZHAUSER L, Hovnanians N, Eshtehardi P, Mojadidi MK, et al
    Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study.
    Heart Vessels. 2017 Mar 16. doi: 10.1007/s00380-017-0957.
    Abstract    

    Abstract available

  54. PARK MH
    Left Heart Disease and Pulmonary Hypertension: Controversy Redefined.
    Methodist Debakey Cardiovasc J. 2016;12.
    Abstract    



  55. FROST AE
    The Intersection of Pulmonary Hypertension and Solid Organ Transplantation.
    Methodist Debakey Cardiovasc J. 2016;12.
    Abstract    

    Abstract available

  56. MARSBOOM G, Chen Z, Yuan Y, Zhang Y, et al
    Aberrant Caveolin-1-Mediated Smad Signaling and Proliferation Identified by Analysis of Adenine 474 Deletion Mutation (c.474delA) in Patient Fibroblasts: A New Perspective in the Mechanism of Pulmonary Hypertension.
    Mol Biol Cell. 2017 Mar 15. pii: mbc.E16-06-0380. doi: 10.1091/mbc.E16-06-0380.
    Abstract    

    Abstract available

  57. JENKINS D, Madani M, Fadel E, D'Armini AM, et al
    Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  58. GOPALAN D, Delcroix M, Held M
    Diagnosis of chronic thromboembolic pulmonary hypertension.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  59. KYZYMLY AV, Ryzhkov AV, Simakova MA, Kozlyonok AV, et al
    [Value of Two Dimensional Echocardiography for Assessment of Disease Severity in Patients With Pulmonary Hypertension].
    Kardiologiia. 2016;56:25-30.
    Abstract    

    Abstract available

  60. MALYKHIN FT, Baturin VA
    [Problems of Diagnosis and Treatment of Pulmonary Hypertension in Old Patients With Chronic Obstructive Pulmonary Disease].
    Kardiologiia. 2016;56:87-96.
    Abstract    

    Abstract available

  61. CHERNYAVSKIY AM, Edemskiy AG, Chernyavskiy MA, Efimenko VG, et al
    [Efficiency of Operation Trombendarterektomy From Pulmonary Artery Branches Depending on the Degree of Pulmonary Hypertension and Duration of Disease].
    Kardiologiia. 2016;56:56-59.
    Abstract    

    Abstract available

  62. NGUYEN QL, Corey C, White P, Watson A, et al
    Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.
    JCI Insight. 2017;2:e91415.
    Abstract    

    Abstract available

  63. NEGI V, Chan SY
    Discerning functional hierarchies of microRNAs in pulmonary hypertension.
    JCI Insight. 2017;2:e91327.
    Abstract    

    Abstract available

  64. MADANI MM
    Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: Pulmonary Thromboendarterectomy.
    Methodist Debakey Cardiovasc J. 2016;12:213-218.
    Abstract    

    Abstract available

  65. FERNANDES TM, Poch DS, Auger WR
    Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.
    Methodist Debakey Cardiovasc J. 2016;12:205-212.
    Abstract    

    Abstract available

  66. MEMON HA, Lin CH, Guha A
    Chronic Thromboembolic Pulmonary Hypertension: Pearls and Pitfalls of Diagnosis.
    Methodist Debakey Cardiovasc J. 2016;12:199-204.
    Abstract    

    Abstract available

  67. MEDREK S, Safdar Z
    Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.
    Methodist Debakey Cardiovasc J. 2016;12:195-198.
    Abstract    

    Abstract available

  68. LUMSDEN AB, Park M
    Diagnostic and Treatment Advances for Chronic Thromboembolic Pulmonary Hypertension.
    Methodist Debakey Cardiovasc J. 2016;12:194.
    Abstract    




  69. Guest Editors Alan Lumsden and Myung Park Oversee Special Issue on Pulmonary Hypertension.
    Methodist Debakey Cardiovasc J. 2016;12:193.
    Abstract    



  70. SERRANO-PARRENO B, Carreton E, Caro-Vadillo A, Falcon-Cordon S, et al
    Pulmonary hypertension in dogs with heartworm before and after the adulticide protocol recommended by the American Heartworm Society.
    Vet Parasitol. 2017;236:34-37.
    Abstract    

    Abstract available

  71. YANAI S, Wakayama M, Nakayama H, Shinozaki M, et al
    Implication of overexpression of dishevelled-associated activator of morphogenesis 1 (Daam-1) for the pathogenesis of human Idiopathic Pulmonary Arterial Hypertension (IPAH).
    Diagn Pathol. 2017;12:25.
    Abstract    

    Abstract available

  72. WU C, Guo J, Liu H, Pudasaini B, et al
    The Correlation of Decreased Heart Rate Recovery and Chronotropic Incompetence with Exercise Capacity in Idiopathic Pulmonary Arterial Hypertension Patients.
    Biomed Res Int. 2017;2017:3415401.
    Abstract    

    Abstract available

  73. COLLUM SD, Amione-Guerra J, Cruz-Solbes AS, DiFrancesco A, et al
    Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.
    Can Respir J. 2017;2017:1430350.
    Abstract    

    Abstract available

  74. MURATA M
    Response to the letter to the editor: Right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension.
    Int J Cardiol. 2017;234:129-130.
    Abstract    



  75. BADAGLIACCA R, Reali M, Poscia R, Pezzuto B, et al
    Letter to the editor about the paper "Right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension" by Murata et al.
    Int J Cardiol. 2017;234:128.
    Abstract    



  76. GUERIN CL, Blandinieres A, Planquette B, Silvestre JS, et al
    Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension.
    Stem Cell Rev. 2017 Mar 11. doi: 10.1007/s12015-017-9732.
    Abstract    

    Abstract available

  77. ZHU Y, Wu Y, Shi W, Wang J, et al
    Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling.
    Life Sci. 2017;173:36-42.
    Abstract    

    Abstract available

  78. SARASHINA T, Nakamura K, Akagi S, Oto T, et al
    Reverse Right Ventricular Remodeling After Lung Transplantation in Patients With Pulmonary Arterial Hypertension Under Combination Therapy of Targeted Medical Drugs.
    Circ J. 2017;81:383-390.
    Abstract    

    Abstract available

  79. ORJI FT, Ujunwa FA, Umedum NG, Ukaegbe O, et al
    The impact of adenotonsillectomy on pulmonary arterial pressure in West African children with adenotonsillar hypertrophy.
    Int J Pediatr Otorhinolaryngol. 2017;92:151-155.
    Abstract    

    Abstract available

  80. SANTOSA A, Tan CS, Teng GG, Fong W, et al
    Lung and gastrointestinal complications are leading causes of death in SCORE, a multi-ethnic Singapore systemic sclerosis cohort.
    Scand J Rheumatol. 2016;45:499-506.
    Abstract    

    Abstract available

  81. REMKOVA A, Simkova I, Valkovicova T, Kaldararova M, et al
    Platelet abnormalities in adults with severe pulmonary arterial hypertension related to congenital heart defects (Eisenmenger syndrome).
    Blood Coagul Fibrinolysis. 2016;27:925-929.
    Abstract    

    Abstract available

  82. HOEPER MM, Apitz C, Grunig E, Halank M, et al
    [Targeted therapy of pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016].
    Dtsch Med Wochenschr. 2016;141.
    Abstract    

    Abstract available

  83. GRUNIG E, Benjamin N, Kruger U, Kaemmerer H, et al
    [General and supportive therapy of pulmonary arterial hypertension].
    Dtsch Med Wochenschr. 2016;141.
    Abstract    

    Abstract available

  84. LEUCHTE HH, Ten Freyhaus H, Gall H, Halank M, et al
    [Risk stratification and follow-up assessment of patients with pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016].
    Dtsch Med Wochenschr. 2016;141.
    Abstract    

    Abstract available

  85. SHINDE SR, Basantwani S, Tendolkar B
    Anesthetic management of patent ductus arteriosus in adults.
    Ann Card Anaesth. 2016;19:750-751.
    Abstract    

    Abstract available

  86. BRAAM EA, Quanjel MJ, Van Haren-Willems JH, Van Oosterhout MF, et al
    Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension.
    Sarcoidosis Vasc Diffuse Lung Dis. 2016;33:182-5.
    Abstract    

    Abstract available

  87. MUNTEAN I, Benedek T, Melinte M, Suteu C, et al
    Deformation pattern and predictive value of right ventricular longitudinal strain in children with pulmonary arterial hypertension.
    Cardiovasc Ultrasound. 2016;14:27.
    Abstract    

    Abstract available

  88. VAID HM, Camacho X, Granton JT, Mamdani MM, et al
    The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario.
    Can Respir J. 2016;2016:6279250.
    Abstract    

    Abstract available

  89. BARNETT CF, Alvarez P, Park MH
    Pulmonary Arterial Hypertension: Diagnosis and Treatment.
    Cardiol Clin. 2016;34:375-89.
    Abstract    

    Abstract available

  90. LEOPOLD JA, Maron BA
    Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2016;17.
    Abstract    

    Abstract available

  91. GEHIN M, Sidharta PN, Dingemanse J
    Bosentan Pharmacokinetics in Pediatric Patients with Pulmonary Arterial Hypertension: Comparison of Dried Blood Spot and Plasma Analysis.
    Pharmacology. 2016;98.
    Abstract    

    Abstract available

  92. TOSSAVAINEN E, Henein MY, Gronlund C, Lindqvist P, et al
    Left Atrial Intrinsic Strain Rate Correcting for Pulmonary Wedge Pressure Is Accurate in Estimating Pulmonary Vascular Resistance in Breathless Patients.
    Echocardiography. 2016;33:1156-65.
    Abstract    

    Abstract available

  93. LOHMANN P, Lee TC, Kearney DL, Fernandes CJ, et al
    Pre-cannulation lung biopsy shortens ECMO course.
    Pediatr Surg Int. 2016;32:713-6.
    Abstract    

    Abstract available

  94. GOLSHAHI J, Sadeghi M, Saqira M, Zavar R, et al
    Exposure to occupational air pollution and cardiac function in workers of the Esfahan Steel Industry, Iran.
    Environ Sci Pollut Res Int. 2016;23:11759-65.
    Abstract    

    Abstract available

  95. YOSHIYUKI R, Tanaka R, Fukushima R, Machida N, et al
    Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension.
    Exp Anim. 2016;65:215-22.
    Abstract    

    Abstract available

  96. NOVO MATOS J, Malbon A, Dennler M, Glaus T, et al
    Intrapulmonary arteriovenous anastomoses in dogs with severe Angiostrongylus vasorum infection: clinical, radiographic, and echocardiographic evaluation.
    J Vet Cardiol. 2016;18:110-24.
    Abstract    

    Abstract available

  97. RAMAMURTHY S, Kelleman MS, McGaughy F, Sachdeva R, et al
    Semiautomatic Evaluation of Tricuspid Annular Plane Systolic Excursion from Two Dimensional Echocardiographic Images.
    Echocardiography. 2016;33:674-80.
    Abstract    

    Abstract available

  98. MANTEGAZZA V, Badagliacca R, Nodari S, Parati G, et al
    Management of heart failure in the new era: the role of scores.
    J Cardiovasc Med (Hagerstown). 2016;17:569-80.
    Abstract    

    Abstract available

  99. KOOPERKAMP H, Mehta I, Fary D, Bates M, et al
    Pulmonary Thromboendarterectomy for Pulmonary Hypertension Before Considering Transplant.
    Ochsner J. 2017;17:66-70.
    Abstract    

    Abstract available

  100. SATOH T
    Improvement in Quality of Life in Chronic Thromboembolic Pulmonary Hypertension With Balloon Pulmonary Angioplasty.
    Circ J. 2017 Mar 22. doi: 10.1253/circj.CJ-17-0176.
    Abstract    



  101. XIAO R, Su Y, Feng T, Sun M, et al
    Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium-Sensing Receptor.
    J Am Heart Assoc. 2017;6.
    Abstract    

    Abstract available

  102. ULRICH S, Hasler ED, Saxer S, Furian M, et al
    Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial.
    Eur Heart J. 2017 Mar 11. doi: 10.1093.
    Abstract    

    Abstract available

  103. NAKWAN N, Kamolvisit W, Napapongsuriya C, Chaiwiriyawong P, et al
    Fatal Vernix Caseosa Aspiration Associated With Persistent Pulmonary Hypertension of the Newborn.
    Pediatr Dev Pathol. 2017;20:168-171.
    Abstract    

    Abstract available

  104. LUNDGREN J, Soderlund C, Radegran G
    Impact of postoperative pulmonary hypertension on outcome after heart transplantation.
    Scand Cardiovasc J. 2017 Mar 22:1-10. doi: 10.1080/14017431.2017.1304569.
    Abstract    

    Abstract available

  105. JHA KK, Subedi N, Prasad Chaudhary D, Lamsal M, et al
    Giant right ventricle secondary to severe pulmonary hypertension.
    BMJ Case Rep. 2017;2017.
    Abstract    



  106. LIU A, Philip J, Vinnakota KC, Van den Bergh F, et al
    Estrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension.
    Physiol Rep. 2017;5.
    Abstract    

    Abstract available

  107. SOM S, Danilov T
    A Depressed Heart: Atrial Fibrillation and Pulmonary Hypertension in Severe Pectus Excavatum.
    Am J Med Sci. 2017;353:414-415.
    Abstract    



  108. ZUHUR SS, Baykiz D, Kara SP, Sahin E, et al
    Relationship Among Pulmonary Hypertension, Autoimmunity, Thyroid Hormones and Dyspnea in Patients With Hyperthyroidism.
    Am J Med Sci. 2017;353:374-380.
    Abstract    

    Abstract available

  109. LAMIA B, Muir JF, Molano LC, Viacroze C, et al
    Altered synchrony of right ventricular contraction in borderline pulmonary hypertension.
    Int J Cardiovasc Imaging. 2017 Mar 19. doi: 10.1007/s10554-017-1110.
    Abstract    

    Abstract available

  110. LEONE MB, Giannotta M, Palazzini M, Cefarelli M, et al
    A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension.
    Radiol Med. 2017 Mar 18. doi: 10.1007/s11547-017-0750.
    Abstract    

    Abstract available

  111. GUO L, Bobhate P, Kumar S, Vadlamudi K, et al
    Hyperoxia Reduces Oxygen Consumption in Children with Pulmonary Hypertension.
    Pediatr Cardiol. 2017 Mar 18. doi: 10.1007/s00246-017-1602.
    Abstract    

    Abstract available

  112. LIM HS, Howell N, Ranasinghe A
    The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension.
    Int J Artif Organs. 2017;40:67-73.
    Abstract    

    Abstract available

  113. CHEN YY, Yun H, Jin H, Kong H, et al
    Association of native T1 times with biventricular function and hemodynamics in precapillary pulmonary hypertension.
    Int J Cardiovasc Imaging. 2017 Mar 17. doi: 10.1007/s10554-017-1095.
    Abstract    

    Abstract available

  114. LI JF, Zhai ZG, Kuang TG, Liu M, et al
    A Case of Pulmonary Hypertension Due to Fistulas Between Multiple Systemic Arteries and the Right Pulmonary Artery in an Adult Discovered for Occulted Dyspnoea.
    Heart Lung Circ. 2017 Feb 22. pii: S1443-9506(17)30070.
    Abstract    

    Abstract available

  115. WEATHERALD J, Taniguchi Y, Humbert M
    Novelties in the Treatment of Pulmonary Hypertension.
    Arch Bronconeumol. 2017 Mar 14. pii: S0300-2896(17)30041.
    Abstract    



  116. LI SH, Li S, Sun L, Bai ZZ, et al
    [Correlation between EGLN1 gene, protein express in lung tissue of rats and pulmonary artery pressure at different altitude].
    Zhonghua Yi Xue Za Zhi. 2016;96:2592-7.
    Abstract    

    Abstract available

  117. DENAULT AY, Bussieres JS, Arellano R, Finegan B, et al
    A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.
    Can J Anaesth. 2016;63:1140-53.
    Abstract    

    Abstract available

  118. HUANG SA, Luo P, Wu YC, He JG, et al
    [Galpha11 expression and effect of sildenafil in muscularization of non-muscular pulmonary arterioles in rat with pulmonary arterial hypertension].
    Zhonghua Yi Xue Za Zhi. 2016;96:1762-5.
    Abstract    

    Abstract available

  119. NAHAR K, Rashid J, Absar S, Al-Saikhan FI, et al
    Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
    Pharm Res. 2016;33:1696-710.
    Abstract    

    Abstract available

  120. THONGSRI W, Bussabawalai T, Leelahavarong P, Wanitkun S, et al
    Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand.
    Expert Rev Pharmacoecon Outcomes Res. 2016;16:525-36.
    Abstract    

    Abstract available

  121. ZORZANELLI L, Maeda N, Clave M, Thomaz A, et al
    Relation of Cytokine Profile to Clinical and Hemodynamic Features in Young Patients With Congenital Heart Disease and Pulmonary Hypertension.
    Am J Cardiol. 2017;119:119-125.
    Abstract    

    Abstract available

  122. BREITLING S, Hui Z, Zabini D, Hu Y, et al
    The mast cell - B-cell axis in lung vascular remodeling and pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2017 Feb 24:ajplung.00311.2016.
    Abstract    

    Abstract available

  123. GRAHAM BB, Koyanagi D, Kandasamy B, Tuder RM, et al
    Right Ventricle Vasculature in Human Pulmonary Hypertension Assessed by Stereology.
    Am J Respir Crit Care Med. 2017 Mar 9. doi: 10.1164/rccm.201702-0425.
    Abstract    



  124. TALWAR S, Rajashekar P, Gupta SK, Gulati GS, et al
    Crossed Pulmonary Arteries in a Patient With Persistent Truncus Arteriosus.
    Ann Thorac Surg. 2016;101:2377-9.
    Abstract    

    Abstract available

  125. SASIKUMAR D, Dharan BS, Menon S, Sivasubramanian S, et al
    Surgical Closure of Aortopulmonary Window in a Topsy-Turvy Heart: A Surgical Challenge.
    Ann Thorac Surg. 2016;101:1982-4.
    Abstract    

    Abstract available

  126. COLQUITT JL, Morris SA, Denfield SW, Fraser CD, et al
    Survival in Children With Down Syndrome Undergoing Single-Ventricle Palliation.
    Ann Thorac Surg. 2016;101:1834-41.
    Abstract    

    Abstract available

  127. FOSHAT M, Boroumand N
    The Evolving Classification of Pulmonary Hypertension.
    Arch Pathol Lab Med. 2017 Mar 16. doi: 10.5858/arpa.2016-0035.
    Abstract    

    Abstract available

  128. TAKEI M, Kawakami T, Kataoka M, Kuwahira I, et al
    Elucidating the Ventilation/Perfusion Mismatch and Reduction of Diffusing Capacity for Carbon Monoxide in Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2017;151:725-726.
    Abstract    



  129. SATOH T, Satoh K, Yaoita N, Kikuchi N, et al
    Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
    Circ Res. 2017 Mar 13. pii: CIRCRESAHA.117.310640.
    Abstract    

    Abstract available

  130. ZHAO QH, Wang L, Pudasaini B, Jiang R, et al
    Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension.
    Clin Cardiol. 2017;40:95-101.
    Abstract    

    Abstract available

  131. SIMONNEAU G, Hoeper MM
    Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2017;49.
    Abstract    



  132. ENDE-VERHAAR YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, et al
    Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.
    Eur Respir J. 2017;49.
    Abstract    

    Abstract available

  133. LAMMERS AE, Bauer UM
    Pulmonary hypertension after timely arterial switch operation in children with simple transposition of the great arteries: a new disease entity?
    Heart. 2017 Mar 16. pii: heartjnl-2016-311105. doi: 10.1136/heartjnl-2016-311105
    Abstract    



  134. GALL H, Felix JF, Schneck FK, Milger K, et al
    The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups.
    J Heart Lung Transplant. 2017 Feb 17. pii: S1053-2498(17)31625.
    Abstract    

    Abstract available

  135. PRICE LC, Wort SJ
    Pulmonary hypertension in ARDS: inflammation matters!
    Thorax. 2017 Feb 23. pii: thoraxjnl-2016-209199.
    Abstract    



  136. DUMAS DE LA ROQUE E, Smeralda G, Quignard JF, Freund-Michel V, et al
    Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.
    PLoS One. 2017;12:e0173044.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;